Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease

Echocardiography

Volumn 32, Issue 3, 2015, Pages 516-521

  Tagliamonte, Ercole ^a   Rigo, Fausto ^b   Cirillo, Teresa ^a   Astarita, Costantino ^c   Quaranta, Gaetano ^a   Marinelli, Umberto ^a   Caruso, Archimede ^a   Romano, Carlo ^a   Capuano, Nicola ^a  

^a Umberto i Hospital   (Italy)

^b OSPEDALE DELL'ANGELO   (Italy)

^c Hospital Santa Maria della Misericordia   (Italy)

Author keywords

coronary flow reserve; dipyridamole; ranolazine; stress echocardiography

Indexed keywords

DIPYRIDAMOLE; PLACEBO; RANOLAZINE; CARDIOVASCULAR AGENT;

AGED; ANGINA PECTORIS; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; DIASTOLE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; COMPLICATION; CORONARY STENOSIS; DRUG EFFECTS; ECHOCARDIOGRAPHY; ECHOGRAPHY; FRACTIONAL FLOW RESERVE; MYOCARDIAL ISCHEMIA; PLACEBO EFFECT; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

CARDIOVASCULAR AGENTS; CORONARY STENOSIS; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PLACEBO EFFECT; RANOLAZINE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84924527109     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/echo.12674     Document Type: Article

References (40)

1. Hale SL, Shryock JC, Belardinelli L, et al. Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol 2008; 44: 954-967.
2. Ju YK, Saint DA, Gage PW,: Hypoxia increases persistent sodium current in rat ventricular myocytes. J Physiol 1996; 497: 337-347.
3. Undrovians AI, Fleidervish IA, Makielski JC,: Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Res 1992; 71: 1231-1241.
4. Antzelevitch C, Belardinelli L, Zygmunt AC, et al. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 2004; 110: 904-910.
5. Hayashida W, van Eyll C, Rousseau MF, et al. Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease. Cardiovasc Drugs Ther 1994; 8: 741-747.
6. Montalescot G, Sechtem U, Achenbach S, et al.: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart J 2013; 34: 2949-3003.
7. Rinkevich D, Belcik T, Gupta NC, et al. Coronary autoregulation is abnormal in syndrome X. insight using myocardial contrast echocardiography. J Am Soc Echocardiogr 2013; 26: 290-296.
8. Lee DH, Youn HJ, Choi YS, et al. Coronary flow reserve is a comprehensive indicator of cardiovascular risk factors in subjects with chest pain and normal coronary angiogram. Circ J 2010; 74: 1405-1414.
9. Mehta PK, Goykhman P, Thomson LE, et al. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging 2011; 4: 514-522.
10. Villano A, Di Franco A, Nerla R, et al. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. Am J Cardiol 2013 Jul 1; 112 (1): 8-13.
11. Armstrong WF, Pellikka PA, Ryan T, et al. Stress echocardiography: Recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 1998; 11: 97-104.
12. Sicari R, Nihoyannopoulos P, Evangelista A, et al. European Association of Echocardiography. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008 Jul; 9 (4): 415-437.
13. Spertus A, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol 1995; 25: 333-341.
14. Paredes-Carbajal MC, Monsalvo I, Hernandez-Diaz C, et al. Effects of ranolazione on vasomotor responses of rat aortic rings. Arch Med Res 2013; 44: 8-12.
15. Makielski JC, Farley AL,: Na(+) current in human ventricle: Implications for sodium loading and homeostasis. J Cardiovasc Electrophysiol 2006; 17: S15-S20.
16. Wagner S, Seidler T, Picht E, et al. Na+-Ca2+ exchanger overexpression predisposes to reactive oxygen species-induced injury. Cardiovasc Res 2003; 60: 404-412.
17. Sossalla S, Wagner S, Rasenack EC, et al. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts-role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol 2008; 45: 32-43.
18. Wang P, Fraser H, Lloyd SG, et al. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. J Pharmacol Exp Ther 2007; 321: 213-220.
19. Belardinelli L, Shryock JC, Fraser H,: Inhibition of the late sodium current as a potential cardioprotective principle: Effects of the late sodium current inhibitor ranolazine. Heart 2006; 92: iv6-iv14.
20. Song Y, Shryock JC, Wagner S, et al. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 2006; 318: 214-222.
21. Undrovinas AI, Belardinelli L, Undrovinas NA, et al. Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. J Cardiovasc Electrophysiol 2006; 17: S169-S177.
22. Fredj S, Lindegger N, Sampson KJ, et al. Altered Na+ channels promote pause-induced spontaneous diastolic activity in long QT syndrome type 3 myocytes. Circ Res 2006; 99: 1225-1232.
23. Wang GK, Calderon J, Wang SY,: State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine. Mol Pharmacol 2008; 73: 940-948.
24. Chaitman BR, Skettino SL, Parker JO, et al. (MARISA Investigators): Antiischemic effects and long-term survivial during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol 2004; 43: 1375-1382.
25. Chaitman BR, Pepine CJ, Parker JO, et al. Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators. Effects of ranolazine with atenolol, alodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trial. J Am Med Assoc 2004; 291: 309-316.
26. Morrow DA, Scirica BM, Karwatoswska-Prokopczuk E, et al. MERLIN-TIMI 36 Trial Investigators. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes. The MERLIN-TIMI 36 Randomized Trial. JAMA 2007; 297: 1775-1783.
27. Scirica BM, Morrow DA, Hod H, et al. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: Results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 2007; 116: 1647-1652.
28. Hozumi T, Yoshida K, Akasaka T, et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: Comparison with invasive technique. J Am Coll Cardiol 1998; 32: 1251-1259.
29. Caiati C, Montaldo C, Zedda N, et al. New non invasive method for coronary flow reserve assessment: Contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 1999; 99: 771-778.
30. Daimon M, Watanabe H, Yamagishi H, et al. Physiologic assessment of coronary artery stenosis by coronary flow reserve measurements with transthoracic Doppler echocardiography: Comparison with exercise thallium-201 single piston emission computed tomography. J Am Coll Cardiol 2001; 37: 1310-1315.
31. Takeuchi M, Miyazaki C, Yoshitani H, et al. Assessment of coronary flow velocity with transthoracic Doppler echocardiography during dobutamine stress echocardiography. J Am Coll Cardiol 2001; 38: 117-123.
32. Murata E, Hozumi T, Matsumura Y, et al. Coronary flow velocity reserve measurement in three major coronary arteries using transthoracic Doppler echocardiography. Echocardiography 2006; 23: 279-286.
33. Cortigiani L, Rigo F, Gherardi S, et al. Implication of the continuous prognostic spectrum of Doppler echocardiographic derived coronary dlow reserve on left anterior descending artery. Am J Cardiol 2010; 105: 158-162.
34. Atar AI, Altuner TK, Bozbas H, et al. Coronary flow reserve in patients with diabetes mellitus and prediabetes. Echocardiography 2012; 29: 634-640.
35. Cortigiani L, Rigo F, Gherardi S, et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 2007; 50: 1354-1361.
36. Banovic M, Bosiljka VT, Voin B, et al. Prognostic value of coronary flow reserve in asymptomatic moderate or severe aortic stenosis with preserved ejection fraction and nonobstructed coronary arteries. Echocardiography 2014; 31: 428-433.
37. Sicari R, Rigo F, Cortigiani L, et al. Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. Am J Cardiol 2009; 103: 626-631.
38. Rigo F, Sicari R, Gherardi S, et al. Prognostic value of coronary flow reserve in medically treated patients with left anterior descending coronary disease with stenosis 51% to 75% in diameter. Am J Cardiol 2007; 100: 1527-1531.
39. Rigo F, Pratali L, Pàlinkàs A, et al. Coronary flow reserve and brachial artery reactivity in patients with chest pain and "false positive" exercise-induced ST-segment depression. Am J Cardiol 2002; 89: 1141-1144.
40. Rosen BD, Lima JA, Nasir K, et al. Lower myocardial perfusion reserve is associated with decreased regional left ventricular function in asymptomatic participants of the multi-ethnic study of atherosclerosis. Circulation 2006; 114: 289-297.